97042 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants; Integrin superfamily Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
a4ß1/7 INTEGRIN LIGAND CONJUGATED COMPOUNDS AND USES THEREOF
#2CIRCULAR RNA AND USE THEREOF
#3De Novo Designed alpha(5) beta(1) Integrin selective minibinders
#4PLATELET TARGETED TREATMENT
#5METHOD FOR DIFFERENTIATING INNATE LYMPHOID CELLS FOR IMMUNOTHERAPY
#6CELL-BASED THERAPIES AND USES THEREOF
#7COMPOUNDS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#8RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
#9METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
#10TREATMENT OF FIBROSIS WITH GENETICALLY-ENGINEERED MACROPHAGES
#11PLATELET TARGETED TREATMENT
#12Dendrimer-exosome hybrid nanoparticles as a delivery platform
#13Cyclic monomer and dimer peptides having integrin antagonist activity
#14Lung cancer diagnosis marker, antibody and application thereof
#15Platelet targeted treatment
#16Platelet targeted treatment
#17ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES
#18Collagen-targeted nanoparticles
#19Bladder cancer tumor marker, antibody and use thereof
#20INTEGRIN HETERODIMER AND AN ALPHA SUBUNIT THEREOF
#21CRKL TARGETING PEPTIDES
#22Anti-alpha2 integrin antibodies and their uses
#23Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
#24Marker for stem cells and its use
#25Method of Screening Drug with the Use of 67 kDa Laminin Receptor and Drug Obtained Thereby
#26Treatment of stroke using domain V of perlecan
#27METHOD FOR INHIBITING OR STIMULATING ANGIOGENESIS IN AN INDIVIDUAL
#28NOVEL RECEPTOR FOR CD40L AND USES THEREOF
#29Integrin Heterodimer and an Alpha Subunit Thereof
#30CELL-BASED COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF THE NERVOUS SYSTEM
#31ANTI-ANGIOGENIC PROTEINS AND FRAGMENTS AND METHODS OF USE THEREOF
#32Novel Peptides and Methods for the Treatment of Inflammatory Disorders
#33Compounds and methods for modulating cell-adhesion mediated drug resistance
#34Anti-α2 integrin antibodies and their uses
#35Method for activating T cell protein tyrosine phosphatase for therapeutic applications
#36Method of screening drug with the use of 67 kDa laminin receptor and drug obtained thereby
#37Marker for stem cells and its use
#38Compounds and methods for modulating cell-adhesion mediated drug resistance
#39Assay methods and amelioration of muscular dystrophy symptoms